The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...
A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...
The world's first reverse aging drug, ER-100, was injected into a human on June 9, 2026 The post The World’s First ...
Billions of dollars are pouring into longevity startups as a growing body of research shows that aging might not be as inevitable as we assumed. Now, a startup claims to have reached a major milestone ...
Beyond headlines and promises of eternal youth, advances in transplants, epigenetic clocks, and cellular reprogramming are redefining aging to help people live longer — and, above all, healthier. Some ...
Mesenchymal drift may help explain how cells lose stable identity and acquire pro-fibrotic, inflammatory mesenchymal traits ...
A novel gene therapy that leads to cellular rejuvenation could restore vision after non-arteritic anterior ischemic optic neuropathy (NAION) and glaucoma. The technique is based on a reprogramming ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...